SEROTYPE-SPECIFIC CHARACTERISTICS OF THE NEUTRALIZING ANTIBODY RESPONSE TO THE SANOFI PASTEUR DENGUE VACCINE IN PHASE III EFFICACY TRIALS

被引：0
|
作者：
Byers, Anthony M. [1 ]
Ross, Shanti [1 ]
Shaik, S. Farzana [1 ]
Peredelchuk, Michael [1 ]
Vernhes, Charlotte [1 ]
de Montfort, Aymeric [2 ]
Small, Robert [1 ]
Bonaparte, Matthew [3 ]
de Silva, Aravinda [4 ]
Moser, Janice M. [1 ]
Guy, Bruno [5 ]
机构：
[1] Sanofi Pasteur, Orlando, FL USA
[2] Sanofi Pasteur, Marcy Letoile, France
[3] Sanofi Pasteur, Swiftwater, PA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Sanofi Pasteur, Lyon, France
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1355
引用
收藏
页码：426 / 426
页数：1
相关论文
共 31 条
  • [1] Sanofi Pasteur's dengue vaccine enters phase III trials
    Riedmann, Eva Maria
    [J]. HUMAN VACCINES, 2010, 6 (12): : 956 - 956
  • [2] Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine
    Gromowski, Gregory D.
    Henein, Sandra
    Kannadka, Chandrika B.
    Barvir, David A.
    Thomas, Stephen J.
    de Silva, Aravinda M.
    Jarman, Richard G.
    [J]. VACCINE, 2018, 36 (18) : 2403 - 2410
  • [3] Sanofi Pasteur shows efficacy of its dengue vaccine in phase 3
    不详
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (06) : 1427 - 1427
  • [4] IMMUNOLOGICAL INVESTIGATIONS TO UNDERSTAND THE OUTCOME OF THE PHASE III EFFICACY STUDIES OF THE SANOFI PASTEUR CANDIDATE DENGUE VACCINE
    Guy, Bruno
    Moser, Janice
    Byers, Antony
    Kachurin, Anatoly
    Harenberg, Anke
    Boudet, Florence
    Dunod, Corinne
    Fanouillere, Karen
    Bonaparte, Matthew
    Jackson, Nicholas
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 165 - 166
  • [5] UPDATE ON THE PHASE III STAGE SANOFI PASTEUR RECOMBINANT TETRAVALENT DENGUE VACCINE
    Lang, Jean
    Saville, Melanie
    Guy, Bruno
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 29 - 29
  • [6] POLYCLONAL ANTIBODY RESPONSES TO SEROTYPE-SPECIFIC NEUTRALIZING EPITOPES IN NATURAL DENGUE VIRUS INFECTIONS
    Andrade, Daniela V.
    Widman, Douglas G.
    de Silva, Aravinda M.
    Baric, Ralph S.
    Harris, Eva
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 39 - 39
  • [7] Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
    Brandler, Samantha
    Lucas-Hourani, Marianne
    Moris, Arnaud
    Frenkiel, Marie-Pascale
    Combredet, Chantal
    Fevrier, Michele
    Bedouelle, Hugues
    Schwartz, Olivier
    Despres, Philippe
    Tangy, Frederic
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2007, 1 (03):
  • [8] USE OF A BIOLAYER INTERFEROMETRY-BASED ASSAY TO DETERMINE ANTIBODY AFFINITY TO DENV FOLLOWING IMMUNIZATION WITH THE SANOFI PASTEUR DENGUE VACCINE IN PHASE II AND PHASE III CLINICAL TRIALS
    Munteanu, Alina
    Karol, Alexander
    de Montfort, Aymeric
    Bonaparte, Matthew
    Guy, Bruno
    Moser, Janice
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 426 - 426
  • [9] From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
    Guy, Bruno
    Barrere, Beatrice
    Malinowski, Claire
    Saville, Melanie
    Teyssou, Remy
    Lang, Jean
    [J]. VACCINE, 2011, 29 (42) : 7229 - 7241
  • [10] Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
    White, Laura J.
    Young, Ellen F.
    Stoops, Mark J.
    Henein, Sandra R.
    Adams, Elizabeth C.
    Baric, Ralph S.
    de Silva, Aravinda M.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
1234